Northern Lights Advisors »

Fate Therapeutics shares owned by Northern Lights Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Northern Lights Advisors from 13F filings

Historical chart of Northern Lights Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Northern Lights Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Northern Lights Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 10k 1.20
2025-12-31 $9.9k 10k 0.98

More positions owned by Northern Lights Advisors

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Northern Lights Advisors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
Acadian Asset Management
Two Sigma Investments
Johnson & Johnson
AQR Capital Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
UBS Group
Goldman Sachs Group
Tang Capital Management

View all funds holding Fate Therapeutics